Consumption of gluten-free products: Should the threshold value for trace amounts of gluten be at 20, 100 or 200 p.p.m.?

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 11, 2006, Pages 1187-1195

  Gibert, Anna ^a,b   Espadaler, Montserrat ^a   Angel Canela, Miguel ^a   Sánchez, Anna ^a   Vaqué, Cristina ^a   Rafecas, Magda ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE   (Spain)

Author keywords

Codex Alimentarius; Coeliac disease; Consumption of gluten free products; Gluten exposure; Gluten threshold; Gluten free diet; Gluten free labelling; Gluten free standard

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BREAD; CELIAC DISEASE; CHILD; FEMALE; FOOD INTAKE; GERMANY; GLUTEN FREE DIET; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; NORWAY; PASTA; PRIORITY JOURNAL; SPAIN;

ADOLESCENT; ADULT; AGE FACTORS; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; DIET SURVEYS; DIETARY CARBOHYDRATES; FEMALE; FOOD TECHNOLOGY; GERMANY; GLUTEN; GLUTENS; HUMANS; INFANT; ITALY; MALE; MIDDLE AGED; NORWAY; REFERENCE VALUES; SEX FACTORS; SPAIN;

EID: 33749826082     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000236884.21343.e4     Document Type: Article

References (68)

1. Mc Manus R, Kelleher D. Celiac disease: the villain unmasked? N Engl J Med 2003; 348:2573-2574.
2. Ciccocioppo R, Di Sabatino A, Corazza GR. Mechanisms of mucosal lesions. In: Catassi C, Fassano A, Corazza GR, editors. The global village of coeliac disease. Perspectives on coeliac disease. Vol II. Pisa: Italian Coeliac Society; 2005. pp. 1-22.
3. Kagnoff MF. Overview and pathogenesis of celiac disease. Gastroenterology 2005; 128:S10-S18.
4. Van de Wal Y, Kooy Y, vanVeelen P, Peña S, Mearin L, Papadopoulus G, et al. Cutting edge: selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998; 161:1585-1588.
5. Bushara KO. Neurologic presentation of celiac disease. Gastroenterology 2005; 128:S92-S97.
6. Catassi C, Bearzi I, Holmes GKT. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 2005; 128:S79-S86.
7. Zone JJ. Skin manifestations of celiac disease. Gastroenterology 2005; 128:S87-S91.
8. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001; 120:636-651.
9. Dewar DH, Ciclitira PJ. Clinical features and diagnosis of celiac disease. Gastroenterology 2005; 128:S19-S24.
10. Green PH. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology 2005; 128:S74-S78.
11. Rewers M. Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology 2005; 128:S47-S51.
12. Fasano A. Celiac disease: how to handle a clinical chameleon. N Engl J Med 2003; 348:2568-2570.
13. DubéC, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, et al. The prevalence of celiac disease in average-risk and at-risk western European populations: a systematic review. Gastroenterology 2005; 128:S57-S67.
14. Mäki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003; 348:2517-2524.
15. Carnicer J, Farre C, Varea V, Vilar P, Moreno J, Artigas J. Prevalence of coeliac disease in Down's syndrome. Eur J Gastroenterol Hepatol 2001; 13:263-267.
16. Murray JA. Celiac disease in patients with an affected member, type 1 diabetes, iron-deficiency, or osteoporosis? Gastroenterology 2005; 128:S52-S56.
17. Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994; 35:1215-1218.
18. Catassi C, Rätsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, Coppa GV, Giorgi PL. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994; 343:200-203.
19. Catassi C, Fabiani E, Rätsch IM, Coppa GV, Giorgi PL, Pierdomenico R, et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl 1996; 412:29-35.
20. Sollid LM, Khosla C. Future therapeutic options for celiac disease. Nat Clin Pract Gastroenterol Hepatol 2005; 2:140-147.
21. Ciclitira PJ, Ellis HJ. Evaluation of a gliadin-containing gluten-free product in coeliac patients. BMJ 1984; 83:289-291.
22. Ciclitira PJ, Cerio R, Ellis HJ, Maxton D, Nelufer JM, Macartney JM. Evaluation of a gliadin-containing gluten-free product in coeliac patients. Hum Nutr Clin Nutr 1985; 39:303-308.
23. Chartrand LJ, Russo PA, Duhaime AG, Seidman EG.Wheat starch intolerance in patients with celiac disease. J Am Diet Assoc 1997; 97:612-618.
24. Kaukinen K, Collin P, Holm K, Rantala I, Vuolteenaho N, Reunala T, et al. Wheat starch-containing gluten free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long-term follow-up study. Scand J Gastroenterol 1999; 34:163-169.
25. Mothes T, Stern M. How gluten-free is gluten-free, and what does this mean to coeliac patients? Eur J Gastroenterol Hepatol 2003; 15:461-463.
26. Peräaho M, Kaukinen K, Paasikivi K, Sievänen H, Lohiniemi S, Mäki M, et al. Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease: prospective and randomized study. Aliment Pharmacol Ther 2003; 17:587-594.
27. Collin P, Thorell L, Kaukinen K, Mäki M. The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease? Aliment Pharmacol Ther 2004; 19:1277-1283.
28. Codex Alimentarius Commission. Codex standard for gluten-free foods. Joint FAO/WHO Food Standards Programme, Rome 118, 1981 (amended 1983).
29. Codex Alimentarius Commission. CX/NFSDU 98/4. Proposed draft revised standard for gluten-free foods. Joint FAO/WHO Food Standards Programme. Codex Committee on Nutrition and Foods for Special Dietary Uses. Twenty-First Session, Berlin, 21-28 September 1998.
30. European Food Safety Authority (EFSA). Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on a request from the Commission relating to the evaluation of allergenic foods for labelling purposes (Request No. EFSA-Q-2003-016) (adopted on 19 February 2004). EFSA J 2004; 32:1-197.
31. Food and Drug Administration, Center for Food Safety and Applied Nutrition (FDA/CFSAN). Approaches to establish thresholds for major food allergens and for gluten in food. Prepared by the Threshold Working Group. US Food and Drug Administration. Center for Food Safety and Applied Nutrition. March 2006.
32. Stern M, Ciclitira PJ, van Eckert R, Feighery C, Janssen FW, Mendez E, et al. Analysis and clinical effects of gluten in coeliac disease. Eur J Gastroenterol Hepatol 2001; 13:741-747.
33. Stern M. A major step towards a practical and meaningful gluten analysis. Eur J Gastroenterol Hepatol 2005; 17:523-524.
34. Valdés I, García E, Llorente M, Méndez E. Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol. Eur J Gastroenterol Hepatol 2003; 15:465-474.
35. García E, Llorente M, Hernando A, Kiefferb R, Wieser H, Méndez E. Development of a general procedure for complete extraction of gliadins for heat processed and unheated foods. Eur J Gastroenterol Hepatol 2005; 17:529-539.
36. Codex Alimentarius Commission. ALINORM 06/29/23. Report of the twenty-seventh session of the codex committee on methods of analysis and sampling. Joint FAO/WHO Food Standards Programme, Budapest 2006.
37. Greco L, Mayer M, Ciccarelli G, Troncone R, Auricchio S. Compliance to a gluten-free diet in adolescents, or 'what do 300 coeliac adolescents eat every day?'. Ital J Gastroenterol Hepatol 1997; 29:305-310.
38. Comment in: Ital J Gastroenterol Hepatol 1997; 29:310-311.
39. Thompson T, Dennis M, Higgins LA, Lee AR, Sharrett MK. Gluten-free diet survey: are Americans with coeliac disease consuming recommended amounts of fibre, iron, calcium and grain foods? J Hum Nutr Dietet 2005; 18:163-169.
40. Costanza MC, Galobardes B, Morabia A. Using percentiles to summarise data instead of means and standard deviations. Soz Praventivmed 2002; 47:427-429.
41. Thompson T. Questionable foods and the glutenfree diet: survey of current recommendations. J Am Diet Assoc 2000; 100:463-465.
42. Janatuinen EK, Pikkarainen PH, Kemppainen TA, Kosma VM, Jarvinen RM, Uusitupa MI, et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995; 333:1033-1037.
43. Thompson T. Do oats belong in a gluten-free diet? J Am Diet Assoc 1997; 97:1413-1416.
44. Mariani P, Viti MG, Montuori M, La Vecchia A, Cipolletta E, Calvani L, et al. The gluten-free diet: a nutritional risk factor for adolescents with celiac disease? J Pediatr Gastroenterol Nutr 1998; 27:519-523.
45. Greco L, Auricchio S, Mayer M, Grimaldi M. Case control study on nutritional risk factors in celiac disease. J Pediatr Gastroenterol Nutr 1988; 7:395-399.
46. Bardella MT, Fredella C, Prampolini L, Molteni N, Giunta AM, Bianchi PA. Body composition and dietary intakes in adult celiac disease patients consuming a strict gluten-free diet. Am J Clin Nutr 2000; 72:937-939.
47. Högberg L, Grodzinsky E, Stenhammar L. Better dietary compliance in patients with coeliac disease diagnosed in early childhood. Scand J Gastroenterol 2003; 38:751-754.
48. Mayer M, Greco L, Troncone R, Auricchio S, Marsh MN. Compliance of adolescents with coeliac disease with a gluten free diet. Gut 1991; 32:881-885.
49. Colaco J, Egan-Mitchell B, Stevens FM, Fottrell PF, McCarthy CF, McNicholl B. Compliance with gluten free diet in coeliac disease. Arch Dis Child 1987; 62:706-708.
50. Fabiani E, Catassi C, Villari A, Gismondi P, Pierdomenico R, Rätsch IM, et al. Dietary compliance in screening-detected coeliac disease adolescents. Acta Paediatr Suppl 1996; 412:65-67.
51. Ljungman G, Myrdal U. Compliance in teenagers with coeliac disease: a Swedish follow-up study. Acta Paediatr 1993; 82:235-238.
52. Ciacci C, Cirillo M, Cavallaro R, Mazzacca G. Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion 2002; 66:178-185.
53. Lee A, Newman JM. Celiac diet: its impact on quality of life. J Am Diet Assoc 2004; 103:1533-1535.
54. van Overbeek FM, Uil-Dieterman IG, Mol IW, Köhler-Brands L, Heymans HS, Mulder CJ. The daily gluten intake in relatives of patients with coeliac disease compared with that of the general Dutch population. Eur J Gastroenterol Hepatol 1997; 9:1097-1099.
55. Catassi C. Celiac disease in Europe. In: Catassi C, Fassano A, Corazza GR, editors. The global village of coeliac disease: perspectives on coeliac disease. Vol. II. Pisa: Italian Coeliac Society; 2005. pp. 71-83.
56. Varea V. Evolución de las estrategias diagnósticas en la enfermedad celíaca (Trends in diagnostic strategies in celiac disease) [in Spanish]. An Esp Pediatr 2000; 53:509-512.
57. Cilleruelo ML, Román E, Jiménez J, Rivero MJ, Barrio J, Castaño A, Campelo O, Fernández A. Enfermedad celiaca silente: explorando el iceberg en población escolar (Silent coeliac disease: exploring the iceberg in the school-aged population) [in Spanish]. An Esp Pediatr 2002; 57:321-326.
58. European Commission. Health statistics: key data on health. 2002 ed. Luxembourg: Office for Official Publications of the European Communities; 2002.
59. Case S. The gluten-free diet: how to provide effective education and resources. Gastroenterology 2005; 128:S128-S134.
60. Kupper C. Dietary guidelines and implementation for celiac disease. Gastroenterology 2005; 128:S121-S127.
61. US Department of Health and Human Services (HHS) and US Department of Agriculture (USDA). Dietary guidelines for Americans. 2005 edition.
62. European Commission Directorate-General for Industry. SCOOP: improvement of knowledge of food consumption with a view to protection of public health by means of exchanges and collaboration between database managers. Reports on tasks for scientific cooperation. Report of experts participating in Task 4.1. European Commission Directorate-General for Industry, Office for Official Publications of the European Communities, Luxembourg. EUR 17528 EN. 1996.
63. Biagi F, Campanella J, Martucci S, Pezzimenti D, Ciclitira PJ, Ellis HJ, Corazza GR. A milligram of gluten a day keeps the mucosal recovery away: a case report. Nutr Rev 2004; 62:360-363.
64. Catassi C, Fabiani E, Mandolesi A, Bearzi I, Iacono G, D'Agate C, et al. The Italian study on gluten microchallenge: preliminary results. In: Stern M, editor. Proceedings of the 19th Meeting of the Working Group on Prolamin Analysis and Toxicity, 30 September-3 October 2004, Prague, Czech Republic. Zwickau: Verlag Wissenschaftliche Scripten; 2005.
65. Hischenhuber C, Crevel R, Jarry B, Mäki M, Moneret-vautrin DA, Romano A, et al. Safe amounts of gluten for patients with wheat allergy or coeliac disease. Aliment Pharmacol Ther 2006; 23:559.
66. Benford D. The acceptable daily intake. A tool for ensuring food safety. Belgium: International Life Sciences Institute; 2000.
67. Ministero della Salute. Direzione Generale Sanità Pubblica Veterinaria, Alimenti e Nutrizione. Oggetto: Prodotti dietetici senza glutine e alimenti di uso corrente non contenenti fonti di glutine (Object: Dietetic gluten-free products and gluten-free food for normal consumption) [in Italian]. Ufficio XII. Ottobre 2003.
68. The European Parliament and the Council of the European Union; for the European Parliament, the president P. Cox; for the Council, the president A. Marzano. Directive 2003/89/EC of the European Parliament and of the Council of 10 November 2003 amending Directive 2000/13/EC as regards indication of the ingredients present in foodstuffs. Official J Eur Union L308:15-18.